Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Disorder
.
Show all posts
Showing posts with label
Disorder
.
Show all posts
Saturday, July 11, 2026
FDA Approves Bysanti (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia
›
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Bysanti (milsaperido...
›
Home
View web version
